'%20fill='%235DDB77'%3e%3cg%20id='Group-11'%20transform='translate(581.000000,%20280.500000)'%3e%3cpath%20d='M138.49874,109.5%20C133.466774,109.5%20128.434809,107.983805%20124.144154,104.950056%20L84.5280975,76.9643007%20C79.7048373,73.5582961%2078.5542478,66.8753537%2081.9518071,62.0401042%20C85.3453007,57.2089306%2092.0116725,56.0486881%2096.8389984,59.4574099%20L136.449634,87.4445239%20C137.674761,88.308592%20139.318654,88.308592%20140.550557,87.4445239%20L180.162547,59.4574099%20C184.974966,56.0514053%20191.644048,57.2021376%20195.052449,62.0401042%20C198.445943,66.8753537%20197.291287,73.5582961%20192.472093,76.9643007%20L152.857392,104.950056%20C148.558605,107.983805%20143.530705,109.5%20138.49874,109.5'%20id='Fill-1'/%3e%3cpath%20d='M138.970865,172.5%20C133.91435,172.5%20128.860554,170.9738%20124.547963,167.928218%20L52.544975,117.037143%20C47.7047009,113.617854%2046.5486927,106.908846%2049.9582368,102.054738%20C53.3677808,97.2047212%2060.0644681,96.0454091%2064.8979422,99.4619702%20L136.894131,150.35441%20C138.133099,151.228668%20139.815431,151.221848%20141.0544,150.347591%20L213.110429,99.4578785%20C217.933023,96.0454091%20224.63923,97.207449%20228.046054,102.058829%20C231.451518,106.912938%20230.29279,113.621945%20225.448436,117.03987%20L153.393767,167.928218%20C149.081177,170.9738%20144.023301,172.5%20138.970865,172.5'%20id='Fill-3'/%3e%3cpath%20d='M91.7065769,265.5%20C86.1958012,265.5%2080.6823087,264.197037%2075.5790343,261.578831%20C24.7024984,235.448622%20-4.72045292,181.542786%200.621888968,124.235602%20C6.3662988,62.6566097%2052.7576038,11.8437763%20113.441337,0.669673594%20C119.294414,-0.369968193%20124.839148,3.47343196%20125.905443,9.31016105%20C126.971738,15.1523476%20123.120851,20.7571356%20117.30445,21.8281576%20C66.0095457,31.2708883%2026.7970551,74.2086399%2021.9464314,126.238482%20C17.4218087,174.722354%2042.3038374,220.332885%2085.3291818,242.421862%20C89.7899625,244.719443%2094.8715036,244.480681%2099.2698008,241.791528%20C103.850115,238.97822%20106.585807,234.11155%20106.585807,228.768719%20C106.585807,222.929261%20103.749598,217.433622%2098.9954166,214.065019%20L56.7416081,184.145984%20C51.9072844,180.729628%2050.7526975,174.014251%2054.1580499,169.163954%20C57.570194,164.31775%2064.2491401,163.141672%2069.0793887,166.571671%20L111.333197,196.490707%20C121.767947,203.877348%20128,215.942377%20128,228.768719%20C128,241.657821%20121.437871,253.387218%20110.444845,260.143525%20C104.644743,263.70041%2098.176339,265.5%2091.7065769,265.5'%20id='Fill-5'/%3e%3cpath%20d='M186.198096,265.5%20C179.652557,265.5%20173.135541,263.705993%20167.294948,260.138459%20C156.468118,253.511283%20150,241.943078%20150,229.18433%20C150,216.130677%20156.336365,203.841593%20166.952662,196.322875%20L208.922079,166.594787%20C213.745323,163.169244%20220.430765,164.331116%20223.838683,169.187496%20C227.24796,174.04251%20226.090707,180.762527%20221.259314,184.179878%20L179.291255,213.917522%20C174.355274,217.412696%20171.413245,223.116928%20171.413245,229.18433%20C171.413245,234.446204%20173.97224,239.021332%20178.426032,241.74784%20C182.949096,244.507115%20188.477286,244.690066%20193.24484,242.209312%20C232.315693,221.855389%20256.586755,181.785138%20256.586755,137.63673%20C256.586755,80.8551824%20216.25542,32.1589534%20160.685569,21.8495575%20C154.8735,20.7696035%20151.032291,15.158212%20152.10533,9.31062323%20C153.171578,3.46030385%20158.782623,-0.400770408%20164.575676,0.681914136%20C230.301368,12.8740616%20278,70.4706949%20278,137.63673%20C278,189.856804%20249.295521,237.24917%20203.095069,261.323541%20C197.733947,264.111488%20191.955835,265.5%20186.198096,265.5'%20id='Fill-8'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Neumora Therapeutics paid its 4 named executives $15.9M in total in FY2025 (Dec). CEO Paul L. Berns was paid $4.6M of that.
Pay$100 in the stock at the end of FY23 → $10
Pay of each named executive
Joshua Pinto, Ph.D.President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Paul L. BernsChief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Bill Aurora, Pharm.D.Chief Strategy Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Henry O. GosebruchFormer President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.